Over many years, Kaken has been marketing a number of its original products under license or distributorship in overseas countries. Such out-licensed products include Mentax, Empynase, Sonifilan, and Fiblast.
Mentax is an antifungal agent launched or approved in Asian countries and the U.S.A.
Empynase is an antiphlogistic enzyme for relief of swelling and difficulty in expectoration and on the market in Korea.
Sonifilan is an immunomodulator to be used for the treatment of uterine cervical cancer in combination with irradiation and on the market in Korea.
Fiblast is a spray formulation to treat skin ulcers such as bed-sore and burns. After obtaining marketing authorization, Daewoong distribute Fiblast in Korea.
|Schering-Plough HealthCare Products||Launched||Lotrimin Ultra(OTC)|